These results suggest that immunoglobulins associated with plasma EVs from patients with GBM may play important roles in EV activities, and the differentially expressed EV proteins tie to prominent cancer signaling pathways (AKT1; p38MAPK; ERK1/2). This evidence concerns the gene MAPK3 and glioblastoma.